The US Departments of Labor, Health and Human Services, and the Treasury recently released Frequently Asked Questions (FAQs) regarding the implementation of certain reporting provisions of the Affordable Care Act (ACA). The FAQs were released to provide clarity on the required drug price disclosures identified in the Transparency in Coverage final rule (the Rule) issued on October 29, 2020. As described in this SHRM article, employers are responsible for making sure that these disclosures are ready and available.
Safe Harbor Issued for Reporting Healthcare Prices Under Transparency Rules
By McDermott Will & Emery on May 17, 2022
Posted In Employee Benefits, Health and Welfare Plans
